Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice

Treating tobacco use and dependence-Clinical practice guideline

Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616 · see citing works

Mortality in relation to smoking: 50 years' observations on male British doctors

Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1× · see citing works

Treating Tobacco Use and Dependence

(2008) · PEDIATRICS · doi:10.1542/peds.2008-1627 · Cited by 2,701 · see citing works

Nicotine replacement therapy for smoking cessation

Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann‐Boyce, J., Cahill, K., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub4 · Cited by 2,514 · see citing works

Smoking and Mental Illness: A Population-Based Prevalence Study

Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508 · see citing works

Physician advice for smoking cessation

Stead, L. F., Buitrago, D., Preciado, N., Sanchez, G., Hartmann-Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000165.pub4 · Cited by 1,955 · see citing works

Nicotine addiction

Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508 · see citing works

Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 1997–2001

Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413 · see citing works

A Clinical Practice Guideline for Treating Tobacco Use and Dependence: 2008 Update

(2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.04.009 · Cited by 1,410 · see citing works

Antidepressants for smoking cessation

Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352 · see citing works

Mortality in relation to smoking: 40 years' observations on male British doctors

Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 1,321 · see citing works

Treating tobacco use and dependence: 2008 update: Clinical practice guideline

(2008) · PsycEXTRA Dataset · doi:10.1037/e481882008-001 · Cited by 1,219 · see citing works

Schizophrenia and increased risks of cardiovascular disease

Hennekens, C. H., Hennekens, A. R., Hollar, D., & Casey, D. E. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.02.007 · Cited by 1,070 · see citing works

Individual behavioural counselling for smoking cessation

Lancaster, T., & Stead, L. F. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001292.pub2 · Cited by 1,015 · see citing works

The Health consequences of smoking: nicotine addiction: a report of the Surgeon General

(1989) · Choice Reviews Online · doi:10.5860/choice.27-1560 · Cited by 882 · see citing works

Nicotine receptor partial agonists for smoking cessation

Hey, K., Lancaster, T., & Bala, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103 · Cited by 864 · see citing works

The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK

Pirie, K., Peto, R., Reeves, G. K., Green, J., & Beral, V. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61720-6 · Cited by 799 · see citing works

Nicotine receptor partial agonists for smoking cessation

Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747 · see citing works

Nicotine replacement therapy for smoking cessation

Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000146.pub3 · Cited by 721 · see citing works

Antidepressants for smoking cessation

Hughes, J., Stead, L., & Lancaster, T. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031 · Cited by 683 · see citing works

Bupropion: a review of its mechanism of antidepressant activity.

Ascher, J. A., Cole, J. O., Colin, J. N., Feighner, J. P., Ferris, R. M., Fibiger, H. C., Golden, R. N., Martin, P., Potter, W. Z., & Richelson, E. (1995) · PubMed · Cited by 680 · see citing works

Effect of Maintenance Therapy With Varenicline on Smoking Cessation<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660 · see citing works

Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders

Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594 · see citing works

Antidepressants for smoking cessation

Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567 · see citing works

Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors

Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558 · see citing works

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Rollema, H., Chambers, L. K., Coe, J. W., Glowa, J., Hurst, R. S., Lebel, L. A., Lu, Y., Mansbach, R. S., Mather, R. J., Rovetti, C. C., et al. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.10.016 · Cited by 533 · see citing works

Avoidable global cancer deaths and total deaths from smoking

Jha, P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2703 · Cited by 522 · see citing works

Weight gain in smokers after quitting cigarettes: meta-analysis

Aubin, H.-J., Farley, A., Lycett, D., Lahmek, P., & Aveyard, P. (2012) · BMJ · doi:10.1136/bmj.e4439 · Cited by 510 · see citing works

Bupropion is a nicotinic antagonist

Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38905-0 · Cited by 509 · see citing works

Relapse prevention interventions for smoking cessation

Hájek, P., Stead, L. F., West, R., Jarvis, M. J., Hartmann‐Boyce, J., & Lancaster, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003999.pub4 · Cited by 471 · see citing works

Physician advice for smoking cessation

Stead, L. F., Bergson, G., & Lancaster, T. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000165.pub3 · Cited by 445 · see citing works

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial

Tashkin, D., Kanner, R. E., Bailey, W. C., Buist, S. A., ANDERSON, P. J., Nides, Gonzales, D. H., Dozier, G., Patel, M., & Jamerson, B. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04724-3 · Cited by 413 · see citing works

A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391 · see citing works

Addressing tobacco among individuals with a mental illness or an addiction

Williams, J. M., & Ziedonis, D. M. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.03.009 · Cited by 356 · see citing works

Nicotine Transdermal Patch and Atypical Antipsychotic Medications for Smoking Cessation in Schizophrenia

George, T. P., Ziedonis, D. M., Feingold, A., Pepper, W. T., Satterburg, C. A., Winkel, J. D., Rounsaville, B. J., & Kosten, T. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1835 · Cited by 354 · see citing works

A Systematic Review of Modafinil

Ballon, J. S., & Feifel, D. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0406 · Cited by 351 · see citing works

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

Aubin, H.-J., Bobak, A., Britton, J. R., Oncken, C., Billing, C. B., Gong, J., Williams, K. E., & Reeves, K. R. (2008) · Thorax · doi:10.1136/thx.2007.090647 · Cited by 344 · see citing works

Interventions for preventing weight gain after smoking cessation

Farley, A., Hájek, P., Lycett, D., & Aveyard, P. N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006219.pub3 · Cited by 333 · see citing works

BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP

Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332 · see citing works

Assessing motivation to quit smoking in people with mental illness: a review

Siru, R., Hulse, G. K., & Tait, R. J. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02545.x · Cited by 301 · cited 1× · see citing works

Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Productivity Losses—United States, 1997-2001

(2005) · JAMA · doi:10.1001/jama.294.7.788 · Cited by 289 · see citing works

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis

Singh, S., Loke, Y. K., Spangler, J. G., & Furberg, C. D. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110218 · Cited by 286 · see citing works

Clonidine for smoking cessation

Gourlay, S. G., Stead, L. F., & Benowitz, N. L. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000058.pub2 · Cited by 248 · see citing works

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study

Tonstad, S. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00003-4 · Cited by 246 · see citing works

The Global Research Neglect of Unassisted Smoking Cessation: Causes and Consequences

Chapman, S. F., & MacKenzie, R. (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000216 · Cited by 237 · see citing works

Placebo-controlled trial of cytisine for smoking cessation

West, R., Zatonski, W., Cedzynska, M., Lewandowska, D., Pazik, J., Aveyard, P., & Stapleton, J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102035 · Cited by 234 · see citing works

Use of drugs, alcohol and tobacco by people with schizophrenia: case–control study

McCreadie, R. G. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.181.4.321 · Cited by 227 · see citing works

Depression and smoking cessation: characteristics of depressed smokers and effects of nicotine replacement.

Kinnunen, T., Doherty, K., Militello, F. S., & Garvey, A. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.4.791 · Cited by 223 · see citing works

Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

Stapleton, J., Watson, L. A., Spirling, L. I., Smith, R. C., Milbrandt, A., Ratcliffe, M., & Sutherland, G. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.02083.x · Cited by 206 · see citing works

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis

Prochaska, J. J., & Hilton, J. F. (2012) · BMJ · doi:10.1136/bmj.e2856 · Cited by 202 · see citing works

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database

Gunnell, D., Irvine, D., Wise, L., Davies, C., & Martin, R. M. (2009) · BMJ · doi:10.1136/bmj.b3805 · Cited by 200 · see citing works

Cytisine for Smoking Cessation

Etter, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1553 · Cited by 195 · see citing works

A randomized trial of nicotine-replacement therapy patches in pregnancy.

Coleman, T., Cooper, S., Thornton, J. G., Grainge, M. J., Watts, K., Britton, J., & Lewis, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109582 · Cited by 190 · see citing works

Varenicline decreases alcohol consumption in heavy-drinking smokers

Mitchell, J., Teague, C. H., Kayser, A. S., Bartlett, S. E., & Fields, H. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2717-x · Cited by 179 · see citing works

Current pharmacological treatments for nicotine dependence

George, T. P., & O’Malley, S. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.003 · Cited by 179 · see citing works

Nicotine receptor partial agonists for smoking cessation

Cahill, K., Stead, L. F., & Lancaster, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub6 · Cited by 177 · see citing works

Analyzing milestones in smoking cessation: Illustration in a nicotine patch trial in adult smokers.

Shiffman, S. S., Scharf, D. M., Shadel, W. G., Gwaltney, C. J., Dang, Q., Paton, S. M., & Clark, D. B. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.2.276 · Cited by 169 · see citing works

Depression and smoking cessation: Characteristics of depressed smokers and effects of nicotine replacement.

Kinnunen, T., Doherty, K., Militello, F. S., et al. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.4.791 · Cited by 168 · see citing works

Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: A systematic review and multiple treatment meta-analysis

Mills, E. J., Wu, P., Lockhart, I., Thorlund, K., Puhan, M. A., & Ebbert, J. O. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.705016 · Cited by 163 · see citing works

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder

Williams, J. M., Anthenelli, R. M., Morris, C. D., Treadow, J., Thompson, J. R., Yunis, C., & George, T. P. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07522 · Cited by 162 · see citing works

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

Berlin, I., Saïd, S., Spreux‐Varoquaux, O., Launay, J., Olivares, R., Millet, V., Lecrubier, Y., & Puech, A. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90058-6 · Cited by 157 · see citing works

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

Lerman, C., Roth, D., Kaufmann, V., Audrain, J., Hawk, L., Liu, A., Niaura, R., & Epstein, L. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00067-4 · Cited by 155 · see citing works

A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers

Agboola, S., McNeill, A., Coleman, T., & Leonardi Bee, J. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02996.x · Cited by 150 · see citing works

Suicidal Behavior and Depression in Smoking Cessation Treatments

Moore, T. J., Furberg, C. D., Glenmullen, J., Maltsberger, J. T., & Singh, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027016 · Cited by 150 · see citing works

The use of bupropion SR in cigarette smoking cessation

Wilkes, S. (2008) · International Journal of COPD · doi:10.2147/copd.s1121 · Cited by 146 · see citing works

Monoamine oxidases and tobacco smoking

Berlin, I., & Anthenelli, R. M. (2001) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145701002188 · Cited by 146 · see citing works

Psychiatric Adverse Events in Randomized, Double-Blind, Placebo-Controlled Clinical Trials of Varenicline: A Pooled Analysis

Tonstad, S., Davies, S., Flammer, M., Russ, C., & Hughes, J. (2010) · Drug Safety · doi:10.2165/11319180-000000000-00000 · Cited by 142 · see citing works

Effect of Nicotine Replacement on the Cigarette Withdrawal Syndrome

West, R., Jarvis, M. J., Russell, M. A., Carruthers, M. E., & Feyerabend, C. (1984) · British Journal of Addiction · doi:10.1111/j.1360-0443.1984.tb00265.x · Cited by 136 · see citing works

Monoamine oxidase A and B activities in heavy smokers

Berlin, I., Saïd, S., Spreux‐Varoquaux, O., Olivares, R., Launay, J., & Puech, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00084-4 · Cited by 131 · see citing works

Combination Nicotine Replacement Therapy for Smoking Cessation

Sweeney, C. T., Fant, R. V., Fagerström, K. O., McGovern, J. F., & Henningfield, J. E. (2001) · CNS Drugs · doi:10.2165/00023210-200115060-00004 · Cited by 128 · see citing works

Update on Pharmacologic Options for Smoking Cessation Treatment

Nides, M. A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.016 · Cited by 128 · see citing works

A preliminary investigation of varenicline for heavy drinking smokers

Fucito, L. M., Toll, B. A., Wu, R., Romano, D. M., Tek, E., & O’Malley, S. S. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2160-9 · Cited by 124 · see citing works

Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy.

Tutka, P., & Zatoński, W. A. (2006) · PubMed · Cited by 123 · see citing works

Varenicline Versus Bupropion SR or Placebo for Smoking Cessation: A Pooled Analysis

Nides, M. (2008) · American Journal of Health Behavior · doi:10.5993/ajhb.32.6.10 · Cited by 121 · see citing works

A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation

Alpert, H. R., Connolly, G. N., & Biener, L. (2012) · Tobacco Control · doi:10.1136/tobaccocontrol-2011-050129 · Cited by 119 · see citing works

Untitled work

(2009) · doi:10.1002/14651858.cd003999.pub3 · Cited by 119 · see citing works

Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial

Shim, J.-C., Jung, D.-U., Jung, S. S., Seo, Y.-S., Cho, D.-M., Lee, J.-H., Lee, S.-W., Kong, B.-G., Kang, J.-W., Oh, M., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.238 · Cited by 112 · see citing works

The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial

NIAURA, R. S., Hays, J. T., Jorenby, D. E., Leone, F. T., Pappas, J. E., Reeves, K. R., Williams, K. E., & Billing, C. B. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802177523 · Cited by 112 · see citing works

Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.

Nides, M. A., Glover, E. D., Reus, V. I., et al. (2009) · PubMed · doi:10.5555/ajhb.2008.32.6.664 · Cited by 110 · see citing works

Use of Oral Topiramate to Promote Smoking Abstinence Among Alcohol-Dependent Smokers

Johnson, B. A., Ait‐Daoud, N., Akhtar, F. Z., & Javors, M. A. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.14.1600 · Cited by 110 · see citing works

Advances in pharmacotherapy for tobacco dependence

Foulds, J., Burke, M. V., Steinberg, M. B., Williams, J. M., & Ziedonis, D. M. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/eoed.9.1.39.32951 · Cited by 107 · see citing works

The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study

Franklin, T. R., Harper, D., Kampman, K. M., Kildea-McCrea, S., Jens, W., Lynch, K. G., O’Brien, C. P., & Childress, A. R. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.02.014 · Cited by 104 · see citing works

Single‐Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

Faessel, H. M., Smith, B. J., Gibbs, M. A., Gobey, J. S., Clark, D. J., & Burstein, A. H. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006290669 · Cited by 104 · see citing works

Prescription Drugs Associated with Reports of Violence Towards Others

Moore, T. J., Glenmullen, J., & Furberg, C. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015337 · Cited by 103 · see citing works

Topiramate in the Treatment of Substance-Related Disorders

Shinn, A. K., & Greenfield, S. F. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08r04062gry · Cited by 103 · see citing works

Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis

Coleman, T. J., Chamberlain, C., Cooper, S. E., & Leonardi‐Bee, J. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03179.x · Cited by 101 · see citing works

Smoking predicts suicidality: Findings from a prospective community study

Bronisch, T., Höfler, M., & Lieb, R. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.010 · Cited by 99 · see citing works

Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects

Foll, B. L., Sokoloff, P., Stark, H., & Goldberg, S. R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300622 · Cited by 97 · see citing works

Long-term use of nicotine chewing gum. Occurrence, determinants, and effect on weight gain

Hajek, P. (1988) · JAMA · doi:10.1001/jama.260.11.1593 · Cited by 97 · see citing works

Management of smoking cessation in patients with psychiatric disorders

Fagerström, K. O., & Aubin, H. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802707568 · Cited by 96 · see citing works

Varenicline and bupropion sustained-release combination therapy for smoking cessation

Ebbert, J. O., Croghan, I. T., Sood, A., Schroeder, D. R., Hays, J. T., & Hurt, R. D. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntn031 · Cited by 95 · see citing works

Nicotine patch therapy prior to quitting smoking: a meta‐analysis

Shiffman, S., & Ferguson, S. G. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02138.x · Cited by 94 · see citing works

Efficacy of N-Acetylcysteine in the Treatment of Nicotine Dependence: A Double-Blind Placebo-Controlled Pilot Study

Schmaal, L., Berk, L., Hulstijn, K. P., Cousijn, J., Wiers, R. W., & van den Brink, W. (2011) · European Addiction Research · doi:10.1159/000327682 · Cited by 93 · see citing works

A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates

Rennard, S. I., Hughes, J., Cinciripini, P. M., Králíková, E., Raupach, T., Arteaga, C., Aubin, L. S., Russ, C., & for the Flexible Quit Date Study Group (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr220 · Cited by 92 · see citing works

Tolerability and Safety of Sustained-Release Bupropion in the Management of Smoking Cessation

Aubin, H. (2002) · Drugs · doi:10.2165/00003495-200262002-00005 · Cited by 87 · see citing works

The Return on Investment of a Medicaid Tobacco Cessation Program in Massachusetts

Richard, P., West, K., & Ku, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029665 · Cited by 86 · see citing works

A national strategy for smoking cessation treatment in England

McNeill, A. D., Raw, M., Whybrow, J., & Bailey, P. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01022.x · Cited by 82 · see citing works

Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: systematic review and meta-analysis

Tsoi, D. T.-Y., Porwal, M., & Webster, A. C. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.109.066019 · Cited by 78 · see citing works

Combination treatment with varenicline and nicotine replacement therapy

Ebbert, J. O., Burke, M. V., Hays, J. T., & Hurt, R. D. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp042 · Cited by 77 · see citing works

A Preliminary Benefit-Risk Assessment of Varenicline in Smoking Cessation

Cahill, K., Stead, L. F., & Lancaster, T. (2009) · Drug Safety · doi:10.2165/00002018-200932020-00005 · Cited by 73 · see citing works

Varenicline

Jimenez-Ruiz, C. A., Berlin, I., & Hering, T. (2009) · Drugs · doi:10.2165/00003495-200969100-00003 · Cited by 72 · see citing works

Long-term Use of Nicotine Chewing Gum

Hájek, P. (1988) · JAMA · doi:10.1001/jama.1988.03410110101035 · Cited by 70 · see citing works

Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study

Weiner, E., Buchholz, A. S., Coffay, A. O., Liu, F., McMahon, R. P., Buchanan, R. W., & Kelly, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.02.003 · Cited by 68 · see citing works

Systematic Biases in Cross-sectional Community Studies may Underestimate the Effectiveness of Stop-Smoking Medications

Borland, R., Partos, T., & Cummings, K. M. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts002 · Cited by 67 · see citing works

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations

Ebbert, J. O. (2010) · Patient Preference and Adherence · doi:10.2147/ppa.s10620 · Cited by 67 · see citing works

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo‐controlled trial

Aubin, H., Lebargy, F., Berlin, I., Bidaut-Mazel, C., Chemali‐Hudry, J., & Lagrue, G. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00814.x · Cited by 66 · see citing works

Vaccines against nicotine

Cerny, E. H., & Cerny, T. (2009) · Human Vaccines · doi:10.4161/hv.5.4.7310 · Cited by 63 · see citing works

An updated meta-analysis of nicotine preloading for smoking cessation: investigating mediators of the effect

Lindson, N., & Aveyard, P. N. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2069-3 · Cited by 63 · see citing works

Preliminary evidence for gender‐specific effects of topiramate as a potential aid to smoking cessation

Anthenelli, R. M., Blom, T. J., McElroy, S. L., & Keck, P. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02148.x · Cited by 61 · see citing works

Bupropion for the treatment of nicotine withdrawal and craving

Mooney, M. E., & Sofuoglu, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.965 · Cited by 61 · see citing works

Non-nicotine pharmacotherapy for smoking cessation.

Ferry, L. (1999) · Primary Care · doi:10.1016/s0095-4543(05)70122-6 · Cited by 60 · see citing works

Efficacy of a nicotine mouth spray in smoking cessation: a randomised, double-blind trial

Tønnesen, P., Lauri, H., Perfekt, R., Mann, K. F., & Batra, A. (2012) · European Respiratory Journal · doi:10.1183/09031936.00155811 · Cited by 60 · see citing works

Pre‐cessation nicotine replacement therapy: pragmatic randomized trial

Bullen, C., Howe, C., Lin, R., Grigg, M., Laugesen, M., McRobbie, H. J., Glover, M., Walker, N. K., Wallace‐Bell, M., Whittaker, R., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02989.x · Cited by 58 · see citing works

Novel Pharmacological Approaches for Treating Tobacco Dependence and Withdrawal

Buchhalter, A. R., Fant, R. V., & Henningfield, J. E. (2008) · Drugs · doi:10.2165/00003495-200868080-00005 · Cited by 57 · see citing works

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial

Aveyard, P. N., Johnson, C. J., Fillingham, S. C., Parsons, A. C., & Murphy, M. F. (2008) · BMJ · doi:10.1136/bmj.39545.852616.be · Cited by 57 · see citing works

Psychiatric Adverse Events Associated with Varenicline: An Intensive Postmarketing Prospective Cohort Study in New Zealand

Harrison-Woolrych, M., & Ashton, J. (2011) · Drug Safety · doi:10.2165/11594450-000000000-00000 · Cited by 54 · see citing works

Effects of topiramate or naltrexone on tobacco use among male alcohol-dependent outpatients

Baltieri, D. A., Daró, F. R., Ribeiro, P. L., & de Andrade, A. G. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.05.025 · Cited by 54 · see citing works

Comparison of Available Treatments for Tobacco Addiction

Herman, A. I., & Sofuoglu, M. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0134-6 · Cited by 53 · see citing works

Pharmacotherapy for Smoking Cessation

Raupach, T., & van Schayck, O. C. P. (2011) · CNS Drugs · doi:10.2165/11590620-000000000-00000 · Cited by 52 · see citing works

A Double-Blind Randomized Placebo-Controlled Pilot Study of Neuropsychiatric Adverse Events in Abstinent Smokers Treated with Varenicline or Placebo

Garza, D., Murphy, M. F., Tseng, L., Riordan, H., & Chatterjee, A. K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.005 · Cited by 50 · see citing works

Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation

Berlin, I., Aubin, H., Pedarriosse, A., Rames, A. D., Lazabemide in Smoking Cessation Study Investigators, Lancrenon, S., & Lagrue, G. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00258.x · Cited by 49 · see citing works

Smoking outcome by psychiatric history after behavioral and varenicline treatment

McClure, J. B., Swan, G. E., Catz, S. L., Jack, L. M., Javitz, H. S., McAfee, T. A., Deprey, M., Richards, J. A., & Zbikowski, S. M. (2010) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2010.03.007 · Cited by 47 · see citing works

The inverse impact law of smoking cessation

Chapman, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60416-5 · Cited by 46 · see citing works

Efficacy and Tolerability of Pharmacotherapies to Aid Smoking Cessation in Adolescents

Bailey, S. R., Crew, E., Riske, E. C., Ammerman, S. D., Robinson, T. N., & Killen, J. D. (2012) · Pediatric Drugs · doi:10.2165/11594370-000000000-00000 · Cited by 43 · see citing works

Differential Involvement of Glutamatergic Mechanisms in the Cognitive and Subjective Effects of Smoking

Jackson, A. E., Nesic, J., Groombridge, C. J., Clowry, O., Rusted, J. M., & Duka, T. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.50 · Cited by 43 · see citing works

Monoamine Oxidase Inhibition for Tobacco Pharmacotherapy

George, T., & Weinberger, A. H. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100474 · Cited by 42 · see citing works

Health consequences of sustained smoking cessation

Bjartveit, K., & Tverdal, A. (2009) · Tobacco Control · doi:10.1136/tc.2008.026898 · Cited by 42 · see citing works

Varenicline: The newest agent for smoking cessation

Potts, L. A., & Garwood, C. L. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060428 · Cited by 41 · see citing works

What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?

Oncken, C. A., & Kranzler, H. R. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp136 · Cited by 41 · see citing works

A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers☆

Weinberger, A. H., Reutenauer, E. L., Jatlow, P. I., O’Malley, S. S., Potenza, M. N., & George, T. P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.009 · Cited by 41 · see citing works

Pharmacotherapy for smoking cessation: present and future

Aubin, H.-J., Karila, L., & Reynaud, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150837 · Cited by 39 · see citing works

An Internet Survey of Use, Opinions and Preferences for Smoking Cessation Medications: Nicotine, Varenicline, and Bupropion

Etter, J., & Schneider, N. G. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts084 · Cited by 38 · see citing works

Smoking and suicidal behaviours in a sample of US adults with low mood: a retrospective analysis of longitudinal data

Covey, L. S., Berlin, I., Hu, M., & Hakes, J. K. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-000876 · Cited by 36 · see citing works

Description of tobacco addiction in pregnant women

Grangé, G., Vayssière, C., Borgne, A., Ouazana, A., L’Huillier, J.-P., Valensi, P. E., Peiffer, G., Aubin, H., Renon, D., Thomas, D., et al. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2004.09.002 · Cited by 35 · see citing works

Placebo-Controlled Trial of Cytisine for Smoking Cessation

West, R., Zatoński, W. A., Cedzyńska, M., Lewandowska, D., Pazik, J., Aveyard, P. N., & Stapleton, J. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000411903.07104.b3 · Cited by 35 · see citing works

Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: Meta-analysis of randomized controlled trials

Kim, Y., Myung, S., Jeon, Y.-J., Lee, E., Park, C.-H., Seo, H. G., & Huh, B. Y. (2011) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp100296 · Cited by 34 · see citing works

Pharmacotherapy for Tobacco Dependence

Fant, R. V., Buchhalter, A. R., Buchman, A. C., & Henningfield, J. E. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_17 · Cited by 33 · see citing works

A placebo-controlled trial of modafinil for nicotine dependence

Schnoll, R. A., Wileyto, E. P., Pinto, A. G., Leone, F. T., Gariti, P., Siegel, S. J., Perkins, K. A., Dackis, C. A., Heitjan, D. F., Berrettini, W. H., et al. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.04.008 · Cited by 33 · see citing works

Failure to improve cigarette smoking abstinence with transdermal selegiline + cognitive behavior therapy

Killen, J. D., Fortmann, S. P., Murphy, G. M., Hayward, C., Fong, D., Lowenthal, K., Bryson, S. W., Killen, D. T., & Schatzberg, A. F. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03020.x · Cited by 32 · see citing works

Tolerability and pharmacokinetics of single and repeated doses of nicotine with The Straw, a novel nicotine replacement product

D'Orlando, K. J., & Fox, B. S. (2004) · Nicotine & Tobacco Research · doi:10.1080/14622200310001656876 · Cited by 31 · see citing works

Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis

Leung, L. K., Patafio, F., & Rosser, W. (2011) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-11-15 · Cited by 31 · see citing works

Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation

Mahmoudi, M., Coleman, C. I., & Sobieraj, D. M. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02877.x · Cited by 28 · see citing works

Comparison of the effects of a 24‐hour nicotine patch and a 16‐hour nicotine patch on smoking urges and sleep

Aubin, H., Luthringer, R., Demazières, A., Dupont, C., & Lagrue, G. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200500489989 · Cited by 28 · see citing works

Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation

Taylor, M. J., Leonardi‐Bee, J., Agboola, S., McNeill, A. D., & Coleman, T. J. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03493.x · Cited by 28 · see citing works

Management of emergent psychiatric symptoms during smoking cessation

Aubin, H. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990802707600 · Cited by 26 · see citing works

Sleep effects of a 24-h versus a 16-h nicotine patch: A polysomnographic study during smoking cessation

Staner, L., Luthringer, R., Dupont, C., Aubin, H., & Lagrue, G. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.09.008 · Cited by 26 · see citing works

Should smokers be offered assistance with stopping?

West, R., McNeill, A. D., Britton, J. R., Bauld, L., Raw, M., Hájek, P., Arnott, D., Jarvis, M. J., & Stapleton, J. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03111.x · Cited by 25 · see citing works

Meta-Analysis of Suicidality in Placebo-Controlled Clinical Trials of Adults Taking Bupropion

Wightman, D. S., Foster, V. J., Krishen, A., Richard, N. E., & Modell, J. G. (2010) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09m00894blu · Cited by 25 · see citing works

A randomized, open‐label pilot comparison of gabapentin and bupropion SR for smoking cessation

White, W. D., Crockford, D. N., Patten, S. B., & el‐Guebaly, N. (2005) · Nicotine & Tobacco Research · doi:10.1080/14622200500259887 · Cited by 25 · see citing works

Dianicline, a Novel 4 2 Nicotinic Acetylcholine Receptor Partial Agonist, for Smoking Cessation: A Randomized Placebo-Controlled Clinical Trial

Tonstad, S., Holme, I., & Tønnesen, P. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntq191 · Cited by 25 · see citing works

A Review of Varenicline’s Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia

Yousefi, M. K., & Folsom, T. D. (2012) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.s4-001 · Cited by 25 · see citing works

Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia

Liu, M., Tsai, S., Jeang, S.-Y., Peng, S.-L., Wu, S.-L., Chen, M., Tsai, Y.-L., & Yang, S.-T. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2011.04.018 · Cited by 25 · see citing works

Oral nicotine solution for smoking cessation: a pilot tolerability study

Westman, E. C., Tomlin, K. F., Perkins, C. E., & Rose, J. E. (2001) · Nicotine & Tobacco Research · doi:10.1080/14622200126973 · Cited by 23 · see citing works

Treatments for nicotine addiction should be a top priority

Pollock, J. D., Koustova, E., Hoffman, A. C., Shurtleff, D., & Volkow, N. D. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60352-4 · Cited by 22 · see citing works

Dependence on the nicotine gum in former smokers

Etter, J. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.10.018 · Cited by 22 · see citing works

Framework Convention on Tobacco Control (FCTC) Article 14 guidelines: a new era for tobacco dependence treatment

Raw, M. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03536.x · Cited by 21 · see citing works

Treatment of comorbid tobacco use in people with serious mental illness

Lising-Enriquez, K., & George, T. P. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0933 · Cited by 20 · see citing works

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

Berlin, I., Hunneyball, I. M., Greiling, D., Jones, S. P., FUDER, H., & Stahl, H.-D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2692-2 · Cited by 20 · see citing works

Novel Pharmacological Approaches to Drug Abuse Treatment

Edens, E. L., Massa, A. A., & Petrakis, I. L. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_29 · Cited by 18 · see citing works

Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking

Walker, N. K., Howe, C., Bullen, C., McRobbie, H. J., Glover, M., Parag, V., Williman, J. A., Veale, R., Nosa, V. H., & Barnes, J. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-880 · Cited by 18 · see citing works

Gabapentin for smoking cessation

Sood, A., Ebbert, J. O., Wyatt, K. D., Croghan, I. T., Schroeder, D. R., Sood, R., & Hays, J. T. (2010) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp195 · Cited by 18 · see citing works

Varenicline in smoking cessation

Tonstad, S., & Rollema, H. (2010) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.27 · Cited by 18 · see citing works

Gabapentin for smoking cessation: A preliminary investigation of efficacy

Sood, A., Ebbert, J. O., Schroeder, D. R., Croghan, I. T., Sood, R., Weg, M. W. V., Wong, G. Y., & Hays, J. T. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200601080307 · Cited by 17 · see citing works

A Double-Blind, Placebo-Controlled Trial of the NMDA Glycine Site Antagonist, GW468816, for Prevention of Relapse to Smoking in Females

Evins, A. E., Pachas, G. N., Mischoulon, D., Urbanoski, K. A., Carlini, S. V., Sousa, J., Bentley, K. H., Rigotti, N. A., Nino, J., Loebl, T., et al. (2011) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31822bb390 · Cited by 14 · see citing works

New Reports Examine Psychiatric Risks of Varenicline for Smoking Cessation

Kuehn, B. M. (2012) · JAMA · doi:10.1001/jama.2011.1924 · Cited by 11 · see citing works

Smoking cessation strategies

Chapman, S., & Wakefield, M. A. (2012) · BMJ · doi:10.1136/bmj.e1732 · Cited by 11 · see citing works

Therapeutic Strategies to Optimize the Efficacy of Nicotine Replacement Therapies

Berlin, I. (2009) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049116 · Cited by 10 · see citing works

EFFECTIVENESS OF NICOTINE REPLACEMENT THERAPY—A REBUTTAL

Hughes, J. R., Cummings, K. M., Foulds, J., Shiffman, S. M., & West, R. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03925.x · Cited by 8 · see citing works

Early Life Origins of Adult Disease and Maternal Smoking During Pregnancy

Aubin, H., Berlin, I., & Reynaud, M. (2012) · American Journal of Public Health · doi:10.2105/ajph.2012.300650 · Cited by 4 · see citing works

Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems

Feldman, C. H., & Anderson, R. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.004 · Cited by 243 · see citing works

Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products

Anderson, G. D., & Chan, L. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0400-9 · Cited by 141 · see citing works

Targeting Aging Pathways in Chronic Obstructive Pulmonary Disease

Easter, M., Bollenbecker, S., Barnes, J. W., & Krick, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186924 · Cited by 125 · see citing works

Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?

Mann, K., Aubin, H.-J., & Witkiewitz, K. (2017) · European Addiction Research · doi:10.1159/000481348 · Cited by 93 · see citing works

Effects of tobacco product use on oral health and the role of oral healthcare providers in cessation: A narrative review

Gajendra, S., McIntosh, S., & Ghosh, S. (2023) · Tobacco Induced Diseases · doi:10.18332/tid/157203 · Cited by 89 · see citing works

Potential of Glial Cell Modulators in the Management of Substance Use Disorders

Jones, J. D. (2020) · CNS Drugs · doi:10.1007/s40263-020-00721-9 · Cited by 78 · see citing works

Does the Regulatory Environment for E-Cigarettes Influence the Effectiveness of E-Cigarettes for Smoking Cessation?: Longitudinal Findings From the ITC Four Country Survey

Yong, H., Hitchman, S. C., Cummings, K. M., Borland, R., Gravely, S. M. L., McNeill, A. D., & Fong, G. T. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx056 · Cited by 70 · see citing works

Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders

Das, S., & Prochaska, J. J. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1361823 · Cited by 59 · see citing works

Multifactorial Etiology of Adolescent Nicotine Addiction: A Review of the Neurobiology of Nicotine Addiction and Its Implications for Smoking Cessation Pharmacotherapy

Mahajan, S. D., Homish, G. G., & Quisenberry, A. J. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.664748 · Cited by 64 · see citing works

Strategies to promote smoking cessation among adolescents

Harvey, J., & Chadi, N. (2016) · Paediatrics & Child Health · doi:10.1093/pch/21.4.201 · Cited by 54 · see citing works

Multi-ancestry transcriptome-wide association analyses yield insights into tobacco use biology and drug repurposing

Chen, F., Wang, X., Jang, S.-K., Quach, B. C., Weissenkampen, J. D., Khunsriraksakul, C., Yang, L., Sauteraud, R., Albert, C. M., Palmer, N. D., et al. (2023) · Nature Genetics · doi:10.1038/s41588-022-01282-x · Cited by 51 · see citing works

Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence

Dürsteler, K. M., Berger, E.-M., Strasser, H., Caflisch, C., Mutschler, J., Herdener, M., & Vogel, M. (2015) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s50807 · Cited by 51 · see citing works

Beliefs and Self-reported Practices of Health Care Professionals Regarding Electronic Nicotine Delivery Systems: A Mixed-Methods Systematic Review and Synthesis

Erku, D., GARTNER, C. E., Morphett, K., & Steadman, K. J. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz046 · Cited by 49 · see citing works

A Conjugate Vaccine Using Enantiopure Hapten Imparts Superior Nicotine-Binding Capacity

Lockner, J. W., Lively, J. M., Collins, K. C., Vendruscolo, J. C. M., Azar, M. R., & Janda, K. D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm501625j · Cited by 37 · see citing works

Dopamine receptor partial agonists and addiction

Moreira, F. A., & Dalley, J. W. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.025 · Cited by 37 · see citing works

Tobacco use disorder and treatment: new challenges and opportunities

Ziedonis, D. M., Das, S., & Larkin, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/dziedonis · Cited by 35 · see citing works

The Effects of Acceptance and Commitment Therapy on Man Smokers' Comorbid Depression and Anxiety Symptoms and Smoking Cessation: A Randomized Controlled Trial.

(2017) · Europe PMC (PubMed Central) · Cited by 35 · see citing works

Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial

Falcone, M., Bernardo, L., Wileyto, E. P., Allenby, C. E., Burke, A. M., Hamilton, R. H., Cristancho, M. A., Ashare, R. L., Loughead, J., & Lerman, C. E. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.10.016 · Cited by 33 · see citing works

Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy Volunteers

Masters, A. R., Gufford, B. T., Lu, J. B. L., Metzger, I. F., Jones, D. R., & Desta, Z. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232876 · Cited by 31 · see citing works

Provider‐Level Variation in Smoking Cessation Assistance Provided in the Cardiology Clinics: Insights From the NCDR PINNACLE Registry

Sardana, M., Tang, Y., Magnani, J. W., Ockene, I. S., Allison, J. J., Arnold, S. V., Jones, P. G., Maddox, T. M., Virani, S. S., & McManus, D. D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011307 · Cited by 28 · see citing works

Impact of E-cigarettes on Smoking and Related Outcomes in Veteran Smokers With Psychiatric Comorbidity

Valentine, G. W., Hefner, K. R., Jatlow, P. I., Rosenheck, R. A., Gueorguieva, R. V., & Sofuoglu, M. (2017) · Journal of Dual Diagnosis · doi:10.1080/15504263.2017.1384877 · Cited by 29 · see citing works

Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro -dihydrobupropion, and threo -dihydrobupropion using HPLC–MS/MS

Masters, A. R., McCoy, M., Jones, D. R., & Desta, Z. (2016) · Journal of Chromatography B · doi:10.1016/j.jchromb.2016.02.018 · Cited by 26 · see citing works

Mecamylamine treatment for alcohol dependence: a randomized controlled trial

Petrakis, I. L., Ralevski, E., Gueorguieva, R. V., O’Malley, S. S., Arias, A. J., Sevarino, K. A., Jane, J. S., O’Brien, E. M., & Krystal, J. H. (2017) · Addiction · doi:10.1111/add.13943 · Cited by 25 · see citing works

Bupropion increases activation in nucleus accumbens during anticipation of monetary reward

Ikeda, Y., Funayama, T., Tateno, A., Fukayama, H., Okubo, Y., & Suzuki, H. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05337-6 · Cited by 26 · see citing works

Human pharmacology for addiction medicine

Quednow, B. B., & Herdener, M. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.017 · Cited by 25 · see citing works

Is it safe to use smoking cessation therapeutics during pregnancy?

Long, N. E. D., Barra, N. G., Hardy, D. B., & Holloway, A. C. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.973846 · Cited by 23 · see citing works

Electrospun α-Lactalbumin Nanofibers for Site-Specific and Fast-Onset Delivery of Nicotine in the Oral Cavity: An In Vitro, Ex Vivo, and Tissue Spatial Distribution Study

Kalouta, K., Stie, M. B., Janfelt, C., Chronakis, I. S., Jacobsen, J. B., Nielsen, H. M., & Foderà, V. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00642 · Cited by 21 · see citing works

“What kind of general practitioner do I need for smoking cessation?” Results from a qualitative study in Poland

Buczkowski, K., Marcinowicz, L., Czachowski, S., Piszczek, E., & Sowińska, A. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-159 · Cited by 20 · see citing works

Electronic nicotine delivery systems (e-cigarettes) as a smoking cessation aid: A survey among pharmacy staff in Queensland, Australia

Erku, D., GARTNER, C. E., Thi, J., Morphett, K., & Steadman, K. J. (2018) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.09.013 · Cited by 19 · see citing works

Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic review

Antoniu, S. A., Buculei, I., Mihaltan, F. D., Crișan-Dabija, R. A., & Trofor, A. C. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1858796 · Cited by 18 · see citing works

“If I’d Known …”—a Theory-Informed Systematic Analysis of Missed Opportunities in Optimising Use of Nicotine Replacement Therapy and Accessing Relevant Support: a Qualitative Study

Herbeć, A., Tombor, I., Shahab, L., & West, R. (2018) · International Journal of Behavioral Medicine · doi:10.1007/s12529-018-9735-y · Cited by 18 · see citing works

Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges

Tijani, A. O., Garg, J., Frempong, D., Verana, G., Kaur, J., Joga, R., Sabanis, C. D., Kumar, S., Kumar, N., & Puri, A. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.034 · Cited by 17 · see citing works

Self-Administration of Cotinine in Wistar Rats: Comparisons to Nicotine

Ding, Z., Gao, Y., Sentir, A. M., & Tan, X. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000367 · Cited by 16 · see citing works

Pharmacotherapy in Tobacco Cessation: A Narrative Review

Pajai, D. D., Paul, P., & Reche, A. R. (2023) · Cureus · doi:10.7759/cureus.35086 · Cited by 16 · see citing works

Integrative Pharmacology in the Treatment of Substance Use Disorders

Donlon, J., Kumari, P., Varghese, S. P., Bai, M. Y., Florentin, O. D., Frost, E. D., Banks, J., Vadlapatla, N., Kam, O., Shad, M. U., et al. (2023) · Journal of Dual Diagnosis · doi:10.1080/15504263.2023.2293854 · Cited by 15 · see citing works

Tobacco cessation programs and factors associated with their effectiveness in the Middle East: A systematic review

Al-Qashoti, M., Aljassim, R., Sherbash, M., Alhussaini, N. W. Z., & Al-Jayyousi, G. F. (2022) · Tobacco Induced Diseases · doi:10.18332/tid/153972 · Cited by 13 · see citing works

The Effects of Long‐Term Varenicline Administration on Ethanol and Sucrose Seeking and Self‐Administration in Male P Rats

Czachowski, C. L., Froehlich, J. C., & DeLory, M. J. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13562 · Cited by 11 · see citing works

L’aide à l’arrêt du tabac des fumeurs atteints de BPCO, d’asthme, de cancer bronchique, et opérés

Perriot, J., Underner, M., Peiffer, G., & Dautzenberg, B. (2018) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2018.03.008 · Cited by 10 · see citing works

Impact of gestational nicotine exposure on intrauterine and fetal infection in a rodent model†

von Chamier, M., Reyes, L., Hayward, L. F., & Brown, M. B. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox025 · Cited by 10 · see citing works

Anesthesiologists and the Other Pandemic: Tobacco Use

Warner, D. O. (2022) · Anesthesiology · doi:10.1097/aln.0000000000004346 · Cited by 9 · see citing works

Effets de l’activité physique sur le syndrome de sevrage et le craving à l’arrêt du tabac

Underner, M., Perriot, J., Peiffer, G., & Meurice, J.-C. (2016) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2015.09.009 · Cited by 9 · see citing works

Impact of a pharmacy-led smoking cessation clinic in a dermatology centre

Cheng, H., Liu, W., Chua, G., Liew, C., Li, W., Choo, W., & Oon, H. H. B. (2018) · Singapore Medical Journal · doi:10.11622/smedj.2018063 · Cited by 9 · see citing works

Lack of effects of simvastatin on smoking cessation in humans: A double-blind, randomized, placebo-controlled clinical study

Ingrand, I., Solinas, M., Ingrand, P., Dugast, E., Saulnier, P., Pérault‐Pochat, M., & Lafay‐Chebassier, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-21819-7 · Cited by 9 · see citing works

Adherence to a digital therapeutic mediates the relationship between momentary self-regulation and health risk behaviors

Plaitano, E. G., McNeish, D., Bartels, S. M., Bell, K. R., Dallery, J., Grabinski, M. J., Kiernan, M., Lavoie, H. A., Lemley, S. M., Lowe, M. R., et al. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1467772 · Cited by 9 · see citing works

Smoking Habits and Attitudes in Students of the Third Faculty of Medicine of Charles University in Prague

Schneidrová, D., Herotová, T. K., Šustková-Fišerová, M., & Hynčica, V. (2016) · Central European Journal of Public Health · doi:10.21101/cejph.a4472 · Cited by 8 · see citing works

Two-Year Therapeutic Effectiveness of Varenicline for Smoking Cessation in a Real World Setting

Pascual, F. P., Ferrándiz, J. F., Sanchez, M. C. G., Lorenzo, F. P., & Estrella, C. B. (2016) · Substance Use & Misuse · doi:10.3109/10826084.2015.1018547 · Cited by 7 · see citing works

Identifying Behavior Change Techniques Used in Tobacco Cessation Interventions by Oral Health Professionals and Their Relation to Intervention Effects—A Review of the Scientific Literature

Moafa, I., Hoving, C., van den Borne, B. H. P., & Jafer, M. A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147481 · Cited by 7 · see citing works

Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation

Annemans, L., Marbaix, S., Nackaerts, K., & Bartsch, P. (2015) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2015.03.004 · Cited by 7 · see citing works

Are smoking cessation treatments associated with suicidality risk? An overview

Penberthy, J. K., Penberthy, J. M., Harris, M. R., Nanda, S., Ahn, J., Martinez, C. P., Osika, A. O., Slepian, Z. A., Forsyth, J. C., Starr, J. A., et al. (2016) · Substance Abuse: Research and Treatment · doi:10.4137/sart.s33389 · Cited by 6 · see citing works

Repurposing drugs for treatment of alcohol use disorder

Aubin, H. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.02.002 · Cited by 6 · see citing works

Effect of cognitive behavior therapy on abstinence among healthy smokers: a systematic review and meta-analysis of randomized controlled trials

Kumar, R., Malhotra, P., Vishwas, A. S., Beniwal, K., & Charan, G. S. (2025) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2025.0019 · Cited by 6 · see citing works

Duration of varenicline prescription and efficacy of smoking cessation treatment: an observational study in Taiwan

Wen, Y., Wang, I.-T., Hu, Y.-T., Cheng, H., Cheng, K., Shiu, M., & Tsai, Y. (2022) · Preventive Medicine · doi:10.1016/j.ypmed.2022.107091 · Cited by 6 · see citing works

Substance use disorders in hospice palliative care: A narrative review of challenges and a case for physician intervention

Rudy, L., & Lacroix, E. (2024) · Palliative & Supportive Care · doi:10.1017/s1478951523001402 · Cited by 6 · see citing works

Pharmacological intervention and abstinence in smokers undergoing cessation treatment: A psychophysiological study

Cui, Y., Engelmann, J. M., Xian, J. Z., Minnix, J. A., Lam, C. Y., Karam‐Hage, M., Cinciripini, P. M., & Robinson, J. D. (2017) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2017.12.001 · Cited by 6 · see citing works

Illicit Drugs Addiction among Patients with Chronic Diseases: Simple Review Article

Alruwaili, N. S. Q., Mohammad, A. A. T., Alnathir, H. F. S., Alfeheid, M. H. S., & Alshammari, N. N. Z. (2022) · Pharmacophore · doi:10.51847/hkrzeuao0u · Cited by 6 · see citing works

Relapse to cotinine seeking in rats: differential effects of sex

Tan, X., Neslund, E. M., & Ding, Z. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000696 · Cited by 6 · see citing works

Nicotine effects on associative learning in human non-smokers

Hahn, B., Wells, A. K., Lenartowicz, A., & Yuille, M. B. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0183-9 · Cited by 6 · see citing works

Effect of Patient Empowerment Model on Smoking Cessation: Randomized Controlled Trial

Khafagy, G. M., Mahmoud, M. M., & Soliman, S. (2021) · Korean Journal of Family Medicine · doi:10.4082/kjfm.20.0212 · Cited by 6 · see citing works

The Effect of Nicotine Dependence on the Risk of Developing Post-traumatic Stress Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Ibrahim, C., Foll, B. L., & Hassan, A. N. (2021) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntab229 · Cited by 6 · see citing works

Poor Practitioner Adherence to Clinical Tobacco Use Guidelines in Liver Transplant Recipients

Harrington, C., Kosirog, M., Campbell, P., Gregory, D., Daud, A., Levitsky, J., Holl, J. L., Lloyd‐Jones, D. M., & VanWagner, L. B. (2022) · Transplantation Direct · doi:10.1097/txd.0000000000001288 · Cited by 6 · see citing works

Efficacité de l’activité physique dans l’aide à l’arrêt du tabac

Underner, M., Perriot, J., Peiffer, G., & Meurice, J.-C. (2015) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2015.01.006 · Cited by 6 · see citing works

Exploring the Role of DARPP-32 in Addiction: A Review of the Current Limitations of Addiction Treatment Pathways and the Role of DARPP-32 to Improve Them

Greener, M.-R., & Storr, S. J. (2022) · NeuroSci · doi:10.3390/neurosci3030035 · Cited by 5 · see citing works

Fluorocitrate inhibition of astrocytes reduces nicotine self-administration and alters extracellular levels of glutamate and dopamine within the nucleus accumbens in male wistar rats

Tan, X., Neslund, E. M., Fentis, K., & Ding, Z. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110001 · Cited by 6 · see citing works

Addressing Smoking in Musculoskeletal Specialty Care

Thayer, L. S., Tiffany, E. M., & Carreira, D. S. (2021) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.21.00108 · Cited by 4 · see citing works

Isolation and characterization of five novel disulfide-poor conopeptides from Conus marmoreus venom

Fu, Y., Zhang, Y., Ju, S., Ma, B., Huang, W., & Luo, S. (2022) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2021-0116 · Cited by 5 · see citing works

Predictors of long-term abstinence in a randomized controlled trial of smoking cessation by mobile phone text messaging (‘Happy Quit’) in China

Liao, Y., Wang, Y., Tang, J., Wu, Q., Wu, Z., & McNeill, A. D. (2022) · Tobacco Prevention & Cessation · doi:10.18332/tpc/152255 · Cited by 5 · see citing works

Sevrage tabagique : les stratégies pharmacologiques différentes des traitements standards

Underner, M., Perriot, J., Peiffer, G., Harika‐Germaneau, G., & Jaafari, N. (2018) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2018.04.008 · Cited by 5 · see citing works

Le tabagisme et l’aide à l’arrêt du tabac des patients atteints de tuberculose

Perriot, J., Underner, M., & Peiffer, G. (2018) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2018.09.002 · Cited by 5 · see citing works

Estimated Budget Impact of Adopting the Affordable Care Act’s Required Smoking Cessation Coverage on United States Healthcare Payers

Baker, C. L., Ferrufino, C. P., Bruno, M., & KOWAL, S. L. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0446-y · Cited by 5 · see citing works

Mental Health and Behavioral Disorders in Pregnancy

Wisner, K. L., Sit, D. K. Y., Bogen, D. L., Altemus, M. M., Pearlstein, T. B., Svikis, D. S., Misra, D. P., & Miller, E. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00055-x · Cited by 4 · see citing works

Des stratégies pour promouvoir l'abandon du tabac chez les adolescents

Harvey, J., & Chadi, N. (2016) · Paediatrics & Child Health · doi:10.1093/pch/21.4.205 · Cited by 4 · see citing works

Health Psychology in Australia

Dorrian, J., Thorsteinsson, E., Benedetto, M. D., Lane-Krebs, K., Day, M., Hutchinson, A., & Sherman, K. (2017) · Cambridge University Press eBooks · doi:10.1017/9781316779156 · Cited by 3 · see citing works

Selection of Optimal Tobacco Cessation Medication Treatment in Patients With Cancer

Wippold, R., Karam‐Hage, M., Blalock, J. A., & Cinciripini, P. M. (2015) · Clinical journal of oncology nursing · doi:10.1188/15.cjon.170-175 · Cited by 4 · see citing works

L-theanine attenuates nicotine reward and withdrawal signs in mice

Alkhlaif, Y., El-Halawany, M. S., Toma, W. B., Park, A. J., Hamouda, A. K., & Damaj, M. I. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137279 · Cited by 4 · see citing works

The Effect of Individual and Group Education Done by Nurses on Smoking Dependency and Smoking Cessation Motivation in Patients with Coronary Artery Disease.

Badrooh, A., Mozaffari, N., Barikani, A., & Dadkhah, B. (2020) · PubMed Central · doi:10.22122/ahj.v12i4.286 · Cited by 4 · see citing works

Le sevrage tabagique

Peiffer, G., Underner, M., Perriot, J., Paillot, N., & Renolleau, F. (2013) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(13)70495-6 · Cited by 4 · see citing works

Prevalence and predictors of indoor second-hand smoke among the non-smoker household population in India: Evidence from the Demographic and Health Survey (DHS) 2021 dataPreprint

Tikhute, V. R., Devkate, K., & Gawai, P. (2026) · medRxiv · doi:10.64898/2026.01.18.26344347 · Cited by 4 · see citing works

Evidence-based carotid artery–based interventions for stroke risk reduction

Ozaki, C. K., Sobieszczyk, P. S., Ho, K. J., McPhee, J. T., & Gravereaux, E. C. (2014) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2014.01.002 · Cited by 3 · see citing works

Feeding Two Birds with One Scone: The Case of Varenicline

Aubin, H., & Luquiens, A. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12907 · Cited by 3 · see citing works

Pharmacotherapy in smoking cessation: Corticotropin Releasing Factor receptors as emerging intervention targets

Sotiriou, I., Chalkiadaki, K., Nikolaidis, C., Sidiropoulou, K., & Chatzaki, Ε. (2017) · Neuropeptides · doi:10.1016/j.npep.2017.02.082 · Cited by 3 · see citing works

Safety Net Provider Attitudes Toward Smoking Cessation Treatment

Meredith, L. R., Baskerville, W., Friedman, T. C., Hurley, B., Dixon, T., Mtume, N., Rodriguez, L., Lopez, B., Hsieh, S., & Ray, L. A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.744816 · Cited by 3 · see citing works

Defining the Role of the Physical Therapist in Addressing Vaping and Smoking Cessation

Dias, K. J., Ferreira, G., Martin, K. J., & Pignataro, R. M. (2022) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/cpt.0000000000000199 · Cited by 3 · see citing works

Acute effects of outdoor and indoor walking on cigarette cravings, withdrawal symptoms and affective response during temporary smoking abstinence

Schöttl, S. E., Insam, K., Frühauf, A., Kopp-Wilfling, P., Holzner, B., & Kopp, M. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06506-4 · Cited by 3 · see citing works

Smoking Intervention Practices in Texas Healthcare Centers with Sexual and Gender Minority Patients

Taing, M., Le, K., Britton, M., Chen, T. A., Parent, M. C., Tamí-Maury, I. M., Leal, I. M., Rogova, A., Kyburz, B., Williams, T., et al. (2022) · Health Behavior and Policy Review · doi:10.14485/hbpr.9.6.1 · Cited by 3 · see citing works

Chapter 34. Nicotine and Public Health

Cummings, K. M., Borland, R., & Braak, D. C. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb34 · Cited by 3 · see citing works

Drug delivery strategies for the treatment of relapse behavior in substance use disorder- A systematic review

Sihag, M., Varma, M., Bhandari, R., & Lawrence, A. J. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-024-01492-8 · Cited by 2 · see citing works

Exercise-based interventions for smoking cessation: A systematic review and meta-analysis

Singh, B., Petersen, J. M., Miatke, A., Dumuid, D., Szeto, K., Dankiw, K. A., Mellow, M. L., Vaikar, S. J., Eglitis, E., Zhou, M., et al. (2026) · Journal of sport and health science/Journal of Sport and Health Science · doi:10.1016/j.jshs.2026.101138 · Cited by 3 · see citing works

Determination of bupropion by off-line coupling Fe3O4@CuO&GO nanocomposite and ion mobility spectrometry with application to biological samples

Shamsi, F., Sheibani, A., & Shishehbore, M. R. (2023) · Analytical Sciences · doi:10.1007/s44211-023-00371-z · Cited by 2 · see citing works

RISING TRENDS IN CURRENT TOBACCO USE AMONG ACTIVE-DUTY PERSONNEL OF THE ROYAL THAI ARMY IN THAILAND FROM 2017 TO 2022 AND ITS ASSOCIATED METABOLIC RISK FACTORS FOR CARDIOVASCULAR DISEASE IN 2022

Poovieng, J., Jongcherdchootrakul, K., Srisawat, P., Mungthin, M., Rangsin, R., & Sakboonyarat, B. (2024) · Journal of Southeast Asian Medical Research · doi:10.55374/jseamed.v8.198 · Cited by 2 · see citing works

Cytisine compared to combination nicotine replacement therapy to reduce cigarette consumption in relapsed smokers: protocol for a pilot randomized controlled trial

Mir, H. R., Heshmati, J., Mullen, K., Baldwin, A., Quirouette, E., Pipe, A., & Reid, R. D. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-024-01591-4 · Cited by 2 · see citing works

Effective drug therapy for cocaine dependence: a milestone

Dürsteler, K. M., & Vogel, M. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00563-8 · Cited by 2 · see citing works

The Role of Dopamine D3 Receptors in Tobacco Use Disorder: A Synthesis of the Preclinical and Clinical Literature

Butler, K., Foll, B. L., & Ciano, P. D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_392 · Cited by 2 · see citing works

Initiating Pharmacologic Treatment in Tobacco-Dependent Adults

Ellison-Barnes, A., & Galiatsatos, P. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.07.008 · Cited by 2 · see citing works

The Influence of Modifiable Risk Factors on Postoperative Outcomes in Patients Receiving Surgery for Resection for Acoustic Neuroma

Nasrollahi, T. S., Shahrestani, S., Borrelli, M., Hopp, M. L., Wu, A. W., Tang, D. M., & Yu, J. S. (2023) · Ear Nose & Throat Journal · doi:10.1177/01455613231191020 · Cited by 2 · see citing works

Drugs for addiction: a therapeutic area in need of a ‘shot in the arm’

Malizia, A. L., & Ferro, A. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12316 · Cited by 2 · see citing works

Smoking

Ashipala, D. O., Tomas, N., & Joel, M. H. (2020) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-7998-2139-7.ch006 · Cited by 1 · see citing works

Smoking Cessation Treatment in Primary Care

An, H.-J., Lee, C. M., Seo, Y. B., Lee, E. S., & Paek, Y. (2024) · Korean Journal of Family Practice · doi:10.21215/kjfp.2024.14.4.184 · Cited by 1 · see citing works

Older age at smoking initiation predicts successful cessation in adults who smoke: A prospective study

Zhao, S. Z., Chan, S. K., Luk, T. T., Tong, H. S. C., Lai, V., Lam, T. H., Cheung, Y. T. D., & Wang, M. P. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.104742 · Cited by 1 · see citing works

DLPFC rTMS is more effective than sham or orbitofrontal stimulation for smoking cessation and alters frontal brain activity: A double-blind, sham-controlled randomized clinical trial

Li, X., Caulfield, K. A., Carpenter, M. J., Ramakrishnan, V., Herrmann, E. S., Dancy, M. M., & George, M. S. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2026.02.053 · Cited by 1 · see citing works

Epidemics of indoor secondhand smoke in Ghanaian households: Evidence from the Demographic and Health Survey (DHS) 2022

Tikhute, V. R., Fatokun, B. S., Sarpong, A. A., Gawai, P., & Adaka, O. A. (2026) · Journal of Human Behavior in the Social Environment · doi:10.1080/10911359.2026.2698878 · Cited by 1 · see citing works

Review: Pharmacotherapy for smoking cessation

Limsuwat, C., Saito, S., & Halvorson, K. M. (2018) · The Southwest Respiratory and Critical Care Chronicles · doi:10.12746/swrccc.v6i25.482 · Cited by 2 · see citing works

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence

Houezec, J. L., & Aubin, H. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.818978 · Cited by 17 · see citing works

Therapeutic Options in Smoking Cessation

Galant, L. M. (2010) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s5099

Clinical Medicine Reviews in Therapeutics 2010:2 283 Therapeutic Options in Smoking Cessation

Galanti, L. M. (2015)

Using pharmacotherapy to optimize quit rates in smokers

Bostock-Cox, B. (2010) · Nurse Prescribing · doi:10.12968/npre.2010.8.9.78302